Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1967 1
1968 3
1971 2
1972 1
1977 1
1979 1
1981 1
1984 1
1985 2
1986 2
1988 1
1990 6
1991 5
1992 2
1994 1
1995 2
1996 2
1997 4
1998 1
1999 3
2000 1
2001 6
2002 4
2003 9
2004 2
2005 3
2006 2
2007 7
2008 9
2009 4
2010 4
2011 6
2012 5
2013 3
2014 4
2015 1
2016 1
2017 1
2021 2
2022 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Corticobasal degeneration.
Stover NP, Watts RL. Stover NP, et al. Among authors: watts rl. Semin Neurol. 2001;21(1):49-58. doi: 10.1055/s-2001-13119. Semin Neurol. 2001. PMID: 11346025 Review.
Treatment of depression in Parkinson's disease.
Sawabini KA, Watts RL. Sawabini KA, et al. Among authors: watts rl. Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S37-41. doi: 10.1016/j.parkreldis.2004.02.002. Parkinsonism Relat Disord. 2004. PMID: 15109585 Review.
Corticobasal degeneration.
Stover NP, Walker HC, Watts RL. Stover NP, et al. Among authors: watts rl. Handb Clin Neurol. 2007;84:351-72. doi: 10.1016/S0072-9752(07)84048-6. Handb Clin Neurol. 2007. PMID: 18808957 No abstract available.
Spheramine for treatment of Parkinson's disease.
Stover NP, Watts RL. Stover NP, et al. Among authors: watts rl. Neurotherapeutics. 2008 Apr;5(2):252-9. doi: 10.1016/j.nurt.2008.02.006. Neurotherapeutics. 2008. PMID: 18394567 Free PMC article. Review.
Benefits and risks of pharmacological treatments for essential tremor.
Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL. Lyons KE, et al. Among authors: watts rl. Drug Saf. 2003;26(7):461-81. doi: 10.2165/00002018-200326070-00003. Drug Saf. 2003. PMID: 12735785 Review.
Ophthalmologic features of Parkinson's disease.
Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Biousse V, et al. Among authors: watts rl. Neurology. 2004 Jan 27;62(2):177-80. doi: 10.1212/01.wnl.0000103444.45882.d8. Neurology. 2004. PMID: 14745050
Depression and disability in Parkinson's disease.
Cole SA, Woodard JL, Juncos JL, Kogos JL, Youngstrom EA, Watts RL. Cole SA, et al. Among authors: watts rl. J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):20-5. doi: 10.1176/jnp.8.1.20. J Neuropsychiatry Clin Neurosci. 1996. PMID: 8845697 Clinical Trial.
115 results